Puma Biotechnology, Inc.
Puma Biotechnology, Inc. scores highest on Nitro (93) and lowest on Earnings (47). Its PosiPenta is 64.40 out of 100, better than most similar companies.
On the Penta Grid this week, Puma Biotechnology, Inc. is Grid #73 of 837 in the Healthcare sector in United States, and Grid #254 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Puma Biotechnology, Inc. | 64.40 | 50 | 47 | 93 | 77 | 55 |
| GMR Solutions Inc. | 42.85 | 43 | 61 | 53 | 4 | 54 |
| Electra Therapeutics, Inc. | 35.43 | 0 | 26 | 41 | 68 | 42 |
| MiMedx Group, Inc. | 55.55 | 27 | 84 | 56 | 66 | 46 |
| Ironwood Pharmaceuticals, Inc. | 68.90 | 43 | 79 | 66 | 98 | 60 |
| ProKidney Corp. | 35.77 | 0 | 40 | 27 | 57 | 54 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 19.27 |
| P/B ratio | 3.66 |
EEarnings
| Trailing EPS | ₹48.30 |
| Forward EPS | ₹33.15 |
NNitro
| Price | 931.05 |
| 52-week high | 1015.34 |
| 52-week low | 433.79 |
| Fall from 52-week high | 8.3% |
TTorque
| Return on equity (ROE) | 21.97% |
| Debt-to-equity | 0.03 |
AAnchor
| Beta (price swings) | 1.21 |
| Market cap | ₹4,806 Cr |
| Insider holding | 15.37% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Puma Biotechnology, Inc.'s PosiPenta score?
Puma Biotechnology, Inc.'s PosiPenta is 64.40 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Puma Biotechnology, Inc. stand on the Penta Grid?
On the Penta Grid this week, Puma Biotechnology, Inc. is Grid #73 of 837 in the Healthcare sector in United States, and Grid #254 of 4,000 in United States.
Which PosiPenta pillar is strongest for Puma Biotechnology, Inc.?
Nitro (momentum), with a score of 93 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Puma Biotechnology, Inc.?
Earnings (growth), with a score of 47 out of 100: around the middle of similar companies.
Has Puma Biotechnology, Inc.'s PosiPenta changed since last week?
Yes, it fell 0.28 points, from 64.68 to 64.40.
PositoAI is for research and education only and is not investment advice.